HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results

About this update from Heartsciences Inc.

[{"type":"image","alt":"HeartSciences Inc.","displaySize":"","headline":null,"caption":"HeartSciences Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":271,"height":58,"url":"https://media.zenfs.com/en/globenewswire.com/bb8c6c7931166e53de866ed1f7dbdc1d"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/TQBZp3ueg1_7du_2jEqWig--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTkwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/bb8c6c7931166e53de866ed1f7dbdc1d","width":271,"height":58}},"lazy":false},{"type":"text","content":"Southlake, TX, July 24, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (“AI”)-powered medical technology company transforming ECGs/EKGs to enable earlier detection of heart disease, today announced its financial results for the fiscal year ended April 30, 2025, and provided a business update highlighting significant strategic progress.","length":439,"tagName":"p"},{"type":"text","content":"Fiscal 2025 and Business Highlights","length":35,"tagName":"p"},{"type":"text","content":"HeartSciences made substantial advancements during fiscal year 2025, marking a pivotal shift in its strategy to enhance the clinical value of ECGs through AI and cloud-based technologies that can be deployed across diverse healthcare settings—from major hospital systems to mobile nurse-led testing services.","length":308,"tagName":"p"},{"type":"text","content":"MyoVista Insights™ Software Platform","length":36,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"HeartSciences successfully developed and launched its MyoVista Insights, a cloud-native software platform designed to modernize legacy ECG management systems and serve as a marketplace for AI-ECG algorithms. The platform is being designed to be used with existing ECG devices and integrate into hospital EHR systems thus seamlessly integrating itself into clinical workflows while eliminating the need to buy new devices.","length":421,"tagName":"p"}]},{"val":[{"type":"text","content":"MyoVista Insights enables clinical institutions to access both HeartSciences’ and third-party AI-ECG algorithms from the millions of ECG devices already in use globally.","length":169,"tagName":"p"}]},{"val":[{"type":"text","content":"The platform began a phased rollout in May 2025, l...

More updates from Heartsciences Inc.